Literature DB >> 28154400

Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.

Rachel B Issaka1, Maneesh H Singh1, Sachiko M Oshima2, Victoria J Laleau1, Carly D Rachocki1, Ellen H Chen3, Lukejohn W Day1, Urmimala Sarkar2, Ma Somsouk1.   

Abstract

OBJECTIVES: The effectiveness of stool-based colorectal cancer (CRC) screening is contingent on colonoscopy completion in patients with an abnormal fecal immunochemical test (FIT). Understanding system and patient factors affecting follow-up of abnormal screening tests is essential to optimize care for high-risk cohorts.
METHODS: This retrospective cohort study was conducted in an integrated safety-net system comprised of 11 primary-care clinics and one Gastroenterology referral unit and included patients 50-75 years, with a positive FIT between April 2012 and February 2015.
RESULTS: Of the 2,238 patients identified, 1,245 (55.6%) completed their colonoscopy within 1-year of the positive FIT. The median time from positive FIT to colonoscopy was 184 days (interquartile range 140-232). Of the 13% of FIT positive patients not referred to gastroenterology, 49% lacked documentation addressing their abnormal result or counseling on the increased risk of CRC. Of the patients referred but who missed their appointments, 62% lacked documentation following up on the abnormal result in the absence of a completed colonoscopy. FIT positive patients never referred to gastroenterology or who missed their appointment after referrals were more likely to have comorbid conditions and documented illicit substance use compared with patients who completed a colonoscopy.
CONCLUSIONS: Despite access to colonoscopy and a shared electronic health record system, colonoscopy completion after an abnormal FIT is inadequate within this safety-net system. Inadequate follow-up is in part explained by inappropriate screening, but there is an absence of clear documentation and systematic workflow within both primary care and GI specialty care addressing abnormal FIT results.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28154400      PMCID: PMC6597438          DOI: 10.1038/ajg.2016.555

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  45 in total

1.  Practice profile. A safety-net system gains efficiencies through 'eReferrals' to specialists.

Authors:  Alice Hm Chen; Margot B Kushel; Kevin Grumbach; Hal F Yee
Journal:  Health Aff (Millwood)       Date:  2010-05       Impact factor: 6.301

2.  Trends in colorectal cancer test use among vulnerable populations in the United States.

Authors:  Carrie N Klabunde; Kathleen A Cronin; Nancy Breen; William R Waldron; Anita H Ambs; Marion R Nadel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-08       Impact factor: 4.254

3.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

4.  A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey.

Authors:  David A Etzioni; Ninez A Ponce; Susan H Babey; Benjamin A Spencer; E Richard Brown; Clifford Y Ko; Neetu Chawla; Nancy Breen; Carrie N Klabunde
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

5.  Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?

Authors:  Charlotte M Carlson; Katharine A Kirby; Michele A Casadei; Melissa R Partin; Christine E Kistler; Louise C Walter
Journal:  Arch Intern Med       Date:  2010-10-11

6.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

7.  Exploring the limits of the safety net: community health centers and care for the uninsured.

Authors:  Michael K Gusmano; Gerry Fairbrother; Heidi Park
Journal:  Health Aff (Millwood)       Date:  2002 Nov-Dec       Impact factor: 6.301

8.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

Review 9.  Follow-up to abnormal cancer screening tests: considering the multilevel context of care.

Authors:  Jane M Zapka; Heather M Edwards; Veronica Chollette; Stephen H Taplin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-29       Impact factor: 4.254

10.  Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.

Authors:  David W Baker; Tiffany Brown; David R Buchanan; Jordan Weil; Kenzie A Cameron; Lauren Ranalli; M Rosario Ferreira; Quinn Stephens; Kate Balsley; Shira N Goldman; Michael S Wolf
Journal:  BMC Health Serv Res       Date:  2013-04-29       Impact factor: 2.655

View more
  37 in total

1.  Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.

Authors:  Katelyn K Jetelina; Joshua S Yudkin; Stacie Miller; Emily Berry; Alicea Lieberman; Samir Gupta; Bijal A Balasubramanian
Journal:  J Gen Intern Med       Date:  2019-06-21       Impact factor: 5.128

2.  Importance of Age-Specific Insurer Perspective on Lifetime Cost Effectiveness of Colorectal Cancer Screening.

Authors:  Audrey H Calderwood
Journal:  Am J Gastroenterol       Date:  2018-10-29       Impact factor: 10.864

3.  Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.

Authors:  Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

4.  Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.

Authors:  Muhammad Alsayid; Maneesh H Singh; Rachel Issaka; Victoria Laleau; Lukejohn Day; Jeffrey Lee; James Allison; Ma Somsouk
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-13       Impact factor: 11.382

5.  Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Authors:  Vivy T Cusumano; Folasade P May
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

6.  Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.

Authors:  Vivy T Cusumano; Anthony Myint; Edgar Corona; Liu Yang; Jennifer Bocek; Antonio G Lopez; Marcela Zhou Huang; Naveen Raja; Anna Dermenchyan; Lily Roh; Maria Han; Daniel Croymans; Folasade P May
Journal:  Dig Dis Sci       Date:  2021-02-20       Impact factor: 3.199

7.  The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.

Authors:  Rachel Gingold-Belfer; Haim Leibovitzh; Doron Boltin; Nidal Issa; Tsachi Tsadok Perets; Ram Dickman; Yaron Niv
Journal:  United European Gastroenterol J       Date:  2019-02-06       Impact factor: 4.623

8.  Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.

Authors:  Balambal Bharti; Folasade Fola Popoola May; Jesse Nodora; María Elena Martínez; Karina Moyano; Shauntay L Davis; Christian B Ramers; Felipe Garcia-Bigley; Shawne O'Connell; Kevin Ronan; Melissa Barajas; Sheree Gordon; Giselle Diaz; Evelyn Ceja; Meghan Powers; Elva M Arredondo; Samir Gupta
Journal:  Cancer       Date:  2019-09-03       Impact factor: 6.860

9.  Assessing adherence and cost-benefit of colorectal cancer screening for accountable providers.

Authors:  Trace Heavener; Frank W McStay; Victoria Jaeger; Kristen Stephenson; Lauren Sager; James Sing
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-21

10.  Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review.

Authors:  Rachel B Issaka; Patrick Avila; Evans Whitaker; Stephen Bent; Ma Somsouk
Journal:  Prev Med       Date:  2018-10-24       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.